Format

Send to

Choose Destination
Med Sci (Paris). 2019 Nov;35(11):905-907. doi: 10.1051/medsci/2019177. Epub 2019 Dec 17.

["Precision oncology": not yet ready for prime time?]

[Article in French]

Author information

1
UMR 7268 ADÉS, Aix-Marseille, Université/EFS/CNRS ; CoReBio PACA, case 901, Parc scientifique de Luminy, 13288 Marseille Cedex 09, France.

Abstract

The concept of precision oncology is straightforward, but the actual results of treating advanced cancer patients with the targeted drug suggested by genomic analysis have been generally disappointing, indicating that this approach is not yet ready for routine clinical practice. A number of possible improvements can and will be tested by additional clinical trials.

PMID:
31845885
DOI:
10.1051/medsci/2019177

Supplemental Content

Full text links

Icon for EDP Sciences
Loading ...
Support Center